Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study

Funding Information: Dr. Landgren has received grant support from: NCI/NIH, FDA, LLS, Rising Tide Foundation, Memorial Sloan Kettering Cancer Center, MMRF, IMF, Paula, and Rodger Riney Foundation, Perelman Family Foundation, Amgen, Celgene, Janssen, Takeda, Glenmark, Seattle Genetics, Karyopharm; ha...

Full description

Bibliographic Details
Published in:Blood Cancer Journal
Main Authors: Long, Þórir Einarsson, Indriðason, Ólafur Skúli, Pálsson, Runólfur, Rögnvaldsson, Sæmundur, Löve, Þorvarður Jón, Thorsteinsdóttir, Sigrún, Sverrisdóttir, Ingigerður S, Viðarsson, Brynjar, Önundarson, Páll Torfi, Agnarsson, Bjarni Agnar, Sigurðardóttir, Margrét, Þorsteinsdóttir, Ingunn, Ólafsson, Ísleifur, Thordardottir, Asdis Rosa, Eyþórsson, Elías Sæbjörn, Jónsson, Ásbjörn, Gíslason, Gauti Kjartan, Ólafsson, Andri, Steingrímsdóttir, Hlíf, Hultcrantz, Malin, Durie, Brian G.M., Harding, Stephen, Landgren, Ola, Kristinsson, Sigurður Yngvi
Other Authors: Internal Medicine and Emergency Services, Other departments, Faculty of Medicine, Clinical Laboratory Services, Diagnostics and Blood Bank, Office of Division of Clinical Services II, Cancer Center, University of Iceland, Landspitali - The National University Hospital of Iceland
Format: Article in Journal/Newspaper
Language:English
Published: 2022
Subjects:
Online Access:https://hdl.handle.net/20.500.11815/3484
https://doi.org/10.1038/s41408-022-00732-3